iX Biopharma Ltd.

iX Biopharma Ltd.
Stock Exchange Singapore Exchange
EPS
SGD0.02
Market Cap
SGD170.82 M
Shares Outstanding
644.59 M
Public Float
257.95 M

Profile

Address
1 Kim Seng Promenade, No. 14-01
Singapore CE 237994
Singapore
Employees -
Website http://www.ixbiopharma.com
Updated 07/08/2019
iX Biopharma Ltd. engages in the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, as well as male erectile dysfunction. It operates through the following segments: Specialty Pharmaceutical and Chemical Analysis. The Specialty Pharmaceutical segment manufactures and sells pharmaceutical products.

Financials

View All
Created with Highcharts 5.0.14iX Biopharma Ltd.Net Income. Fiscal year is July-June. All values SGD Thousands.5 0825 08210 56110 5617 7037 7037 3907 39015 09415 0942014201520162017201805k10k15k20k
Created with Highcharts 5.0.14iX Biopharma Ltd.Sales/Revenue. Fiscal year is July-June. All values SGD Thousands.6 4876 4877 4457 4455 7975 7976 3816 3816 5336 5332014201520162017201802k4k6k8k

Yip Hang Lee
Chairman & Chief Executive Officer
Shing Tung Ho
Non-Executive Director